Skip to main content
NCBI home page
Nature Portfolio logoLink to Nature Portfolio
. 2022 Sep 1;609(7929):E13. doi: 10.1038/s41586-022-05287-8

Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

Daniel Zingg 1,2,#, Jinhyuk Bhin 1,2,3,#, Julia Yemelyanenko 1,2,#, Sjors M Kas 1,2,#, Frank Rolfs 1,2,4, Catrin Lutz 1,2, Jessica K Lee 5, Sjoerd Klarenbeek 6, Ian M Silverman 7, Stefano Annunziato 1,2, Chang S Chan 8,9, Sander R Piersma 4, Timo Eijkman 1,2, Madelon Badoux 1,2, Ewa Gogola 1,2, Bjørn Siteur 10, Justin Sprengers 10, Bim de Klein 1,2, Richard R de Goeij-de Haas 4, Gregory M Riedlinger 9,11, Hua Ke 8,9, Russell Madison 5, Anne Paulien Drenth 1,2, Eline van der Burg 1,2, Eva Schut 1,2, Linda Henneman 1,2,10, Martine H van Miltenburg 1,2, Natalie Proost 10, Huiling Zhen 12, Ellen Wientjens 1,2, Roebi de Bruijn 1,2,3, Julian R de Ruiter 1,2,3, Ute Boon 1,2, Renske de Korte-Grimmerink 10, Bastiaan van Gerwen 10, Luis Féliz 13, Ghassan K Abou-Alfa 14,15, Jeffrey S Ross 5,16, Marieke van de Ven 10, Sven Rottenberg 1,17,18, Edwin Cuppen 2,19,20, Anne Vaslin Chessex 21, Siraj M Ali 5, Timothy C Burn 7, Connie R Jimenez 4, Shridar Ganesan 8,9,✉, Lodewyk F A Wessels 2,3,✉, Jos Jonkers 1,2,✉
PMCID: PMC9519452  PMID: 36050473

Correction to: Nature 10.1038/s41586-022-05066-5 Published online 10 August 2022

This paper was originally published under a standard Springer Nature license (© The Author(s), under exclusive licence to Springer Nature Limited). It is now available as an open-access paper under a Creative Commons Attribution 4.0 International license, © The Author(s). The error has been corrected in the HTML and PDF versions of the article.

Contributor Information

Shridar Ganesan, Email: ganesash@cinj.rutgers.edu.

Lodewyk F. A. Wessels, Email: l.wessels@nki.nl

Jos Jonkers, Email: j.jonkers@nki.nl.

Articles from Nature are provided here courtesy of Nature Publishing Group

RESOURCES